{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:35:33Z","timestamp":1793298933915,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX004962"],"award-info":[{"award-number":["I01 BX004962"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["LRP0000029120"],"award-info":[{"award-number":["LRP0000029120"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.euf.2026.06.002","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:27:56Z","timestamp":1785529676000},"page":"931-938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Performance of Urine Tumor DNA Detection in Patients with High-grade Non\u2013muscle-invasive Bladder Cancer Undergoing Repeat Transurethral Resection"],"prefix":"10.1016","volume":"12","author":[{"given":"Jay","family":"Ogunkeye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Shkolyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Prendiville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay B.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eila C.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin G.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5702-4586","authenticated-orcid":false,"given":"Vincent T.","family":"Bicocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor G.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2448-5463","authenticated-orcid":false,"given":"Joseph C.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.euf.2026.06.002_b0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.euf.2026.06.002_b0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(09)60491-8","article-title":"Bladder cancer","volume":"374","author":"Kaufman","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.euf.2026.06.002_b0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2026.06.002_b0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non\u2013muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2026.06.002_b0025","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1089\/end.2011.0081","article-title":"Repeated white light transurethral resection of the bladder in nonmuscle-invasive urothelial bladder cancers: systematic review and meta-analysis","volume":"25","author":"Vianello","year":"2011","journal-title":"J Endourol"},{"key":"10.1016\/j.euf.2026.06.002_b0030","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1097\/01.ju.0000181799.81119.fc","article-title":"Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy","volume":"174","author":"Herr","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2026.06.002_b0035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","article-title":"European Association of Urology guidelines on non\u2013muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-A summary of the 2024 guidelines update","volume":"86","author":"Gontero","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2026.06.002_b0040","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","article-title":"Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review","volume":"73","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2026.06.002_b0045","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s10147-019-01581-0","article-title":"The prognostic value of routine second transurethral resection in patients with newly diagnosed stage pT1 non-muscle-invasive bladder cancer: results from randomized 10-year extension trial","volume":"25","author":"Eroglu","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.euf.2026.06.002_b0050","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.urolonc.2020.06.013","article-title":"Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: a systematic review","volume":"38","author":"Mori","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2026.06.002_b0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5489\/cuaj.3143","article-title":"Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of Alberta","volume":"10","author":"Gotto","year":"2016","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.euf.2026.06.002_b0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.purol.2019.11.003","article-title":"Factors affecting guideline adherence in the initial treatment of non-muscle invasive bladder cancer: retrospective study in a French peripheral hospital","volume":"30","author":"Jeglinschi","year":"2020","journal-title":"Prog Urol"},{"key":"10.1016\/j.euf.2026.06.002_b0065","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.euo.2021.04.003","article-title":"Implications of guideline-based, risk-stratified restaging transurethral resection of high-grade ta urothelial carcinoma on Bacillus Calmette-Gu\u00e9rin therapy outcomes","volume":"5","author":"Hensley","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2026.06.002_b0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4111\/icu.20210314","article-title":"Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors","volume":"63","author":"Lee","year":"2022","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.euf.2026.06.002_b0075","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/23523735241303350","article-title":"Repeat TURBT in large volume high-grade non-invasive bladder cancer","volume":"10","author":"Durant","year":"2024","journal-title":"Bladder Cancer (Amsterdam, Netherlands)"},{"key":"10.1016\/j.euf.2026.06.002_b0080","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/JU.0000000000002229","article-title":"Factors associated with re-resection in T1 bladder cancer: identifying patients who do not receive guideline-concordant care at the population level","volume":"207","author":"Wettstein","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2026.06.002_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-09033-7","article-title":"A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euf.2026.06.002_b0090","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/21681805.2013.864327","article-title":"Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancer","volume":"48","author":"Jancke","year":"2014","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euf.2026.06.002_b0095","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1158\/1078-0432.CCR-23-0513","article-title":"Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer","volume":"29","author":"Zhang","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euf.2026.06.002_b0100","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/2159-8290.CD-18-0825","article-title":"Detection and surveillance of bladder cancer using urine tumor DNA","volume":"9","author":"Dudley","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.euf.2026.06.002_b0105","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1158\/1078-0432.CCR-22-3250","article-title":"Cell-free urine and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle-invasive bladder cancer","volume":"29","author":"Christensen","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euf.2026.06.002_b0110","doi-asserted-by":"crossref","first-page":"497.e9","DOI":"10.1016\/j.urolonc.2021.02.011","article-title":"Bladder cancer risk stratification using a urinary mRNA biomarker panel \u2013 A path towards cystoscopy triaging","volume":"39","author":"Shkolyar","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2026.06.002_b0115","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.euros.2024.09.001","article-title":"Xpert bladder cancer detection in emergency setting assessment (XESA project): a prospective, single-centre trial","volume":"71","author":"Sordelli","year":"2025","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euf.2026.06.002_b0120","doi-asserted-by":"crossref","first-page":"326.e1","DOI":"10.1016\/j.urolonc.2023.01.009","article-title":"Cxbladder Monitor testing to reduce cystoscopy frequency in patients with bladder cancer","volume":"41","author":"Li","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2026.06.002_b0125","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.3390\/jcm11195827","article-title":"Urinary comprehensive genomic profiling correlates urothelial carcinoma mutations with clinical risk and efficacy of intervention","volume":"11","author":"Bicocca","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.euf.2026.06.002_b0130","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1158\/1078-0432.CCR-23-0570","article-title":"Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk-prediction","volume":"29","author":"Salari","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euf.2026.06.002_b0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/1878-0261.13530","article-title":"Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapy","volume":"18","author":"Rac","year":"2023","journal-title":"Mol Oncol"},{"key":"10.1016\/j.euf.2026.06.002_b0140","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.euo.2024.09.016","article-title":"Minimal residual disease detection with urine-derived DNA is prognostic for recurrence-free survival in Bacillus Calmette-Gu\u00e9rin\u2013unresponsive non\u2013muscle-invasive bladder cancer treated with Nadofaragene Firadenovec","volume":"8","author":"Narayan","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2026.06.002_b0145","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2025.03.023","article-title":"Urine tumor DNA to stratify the risk of recurrence in patients treated with atezolizumab for Bacillus Calmette-Gu\u00e9rin\u2013unresponsive non\u2013muscle-invasive bladder cancer","volume":"88","author":"St-Laurent","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2026.06.002_b0150","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2026.06.002_b0155","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jnci\/dji237","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK)","volume":"97","author":"McShane","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euf.2026.06.002_b0160","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/nar\/28.1.352","article-title":"dbSNP: a database of single nucleotide polymorphisms","volume":"28","author":"Smigielski","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.euf.2026.06.002_b0165","doi-asserted-by":"crossref","unstructured":"1000 Genomes Project Consortium, Auton A, Brooks LD, et al. A global reference for human genetic variation. Nature 2015;526:68\u201374.","DOI":"10.1038\/nature15393"},{"key":"10.1016\/j.euf.2026.06.002_b0170","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR project GENIE: powering precision medicine through an international consortium","volume":"7","author":"AACR Project GENIE Consortium","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.euf.2026.06.002_b0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.euf.2026.06.002_b0180","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.euf.2026.06.002_b0185","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1093\/nar\/gkr407","article-title":"Predicting the functional impact of protein mutations: application to cancer genomics","volume":"39","author":"Reva","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.euf.2026.06.002_b0190","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"key":"10.1016\/j.euf.2026.06.002_b0195","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000005130","article-title":"Urine Tumor DNA Testing Identifies Recurrence and Monitors Therapy Response in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer Receiving Intravesical Bacillus Calmette-Gu\u00e9rin","author":"Bahlburg","year":"2026","journal-title":"J Urol."}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456926000970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456926000970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:59:06Z","timestamp":1793296746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456926000970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2405456926000970"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2026.06.002","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of Urine Tumor DNA Detection in Patients with High-grade Non\u2013muscle-invasive Bladder Cancer Undergoing Repeat Transurethral Resection","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2026.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}